[ad_1]
BioNTech generates a worrying alarm in Vaccines for COVID-19. The company that – together with Pfizer – has cured the antidote currently most widespread in the West, has announced that other vaccines are urgently needed, given that global demand far exceeds the doses produced. The head of the German startup BioNTech was very clear, Ugur Sahin: if new vaccines are not approved immediately in Europe, your company alone will not be able to cover the great demand. “The situation is not good. A gap has been created because other vaccines have not been approved and we have to cover the hole with ours“Sahin explained in an interview with the German weekly Spiegel. That is why the Germany urged the EMA, the European medicines agency, to approve as soon as possible the vaccine developed by the University of Oxford and AstraZeneca. But the timing of approval remains uncertain.
[ad_2]
